Vesalio has announced that it has obtained its second CE approval spanning multiple new NeVa product designs and technology. The new generation NeVa devices expand on the Drop Zone and Smart Marker technologies while also introducing first to market features such as a distal filter. A controlled launch of the new technology will begin in June in Europe with expected full commercial release in Q4 of this year.
“The new technology looks very promising based on early feedback from several physician KOLs. The positive clinical results that were recently published from our first generation NeVa devices, has led to an increased market interest in NeVa. The expansion of the NeVa platform should provide an excellent opportunity for Vesalio to gain additional market share” commented Steve Rybka, CEO of Vesalio.
The paper: “Mechanical thrombectomy with a novel stent retriever with multifunctional zones: Initial clinical experience with the NeVa thrombectomy device,” was recently published in the Journal of Neuroradiology. The data demonstrated that NeVa achieved a high rate of first pass success and overall reperfusion scores with no device related complications.
